{
  "synthesized_claims": [
    {
      "statement": "The Warburg phenotype's biphasic response to CBD is a direct consequence of its target affinity profile: low doses (<5 \u00b5M) favor cytoprotective TRPV1/PPAR\u03b3 signaling (EC50 2-5 \u00b5M), while cytotoxic effects only manifest when CBD concentrations approach VDAC1's Kd (11 \u00b5M) and can overcome the high-affinity HK-II \"buffer.\"",
      "mechanism": "CBD follows mass-action kinetics, engaging its highest-affinity targets first; protective signaling is initiated before the concentration is sufficient to achieve the high VDAC1 occupancy required for HK-II displacement and apoptosis.",
      "falsifiable_by": "A highly specific VDAC1-binding CBD analog (Kd < 1 \u00b5M) failing to induce apoptosis at low doses in Warburg cells.",
      "type": 0,
      "confidence": 0.77,
      "overlap_count": 5,
      "models": [
        "claude",
        "deepseek",
        "gemini",
        "grok",
        "mistral"
      ],
      "tuples": "frozenset({('cbd', 'interacts', 'trpv1'), ('trpv1', 'interacts', 'ec50'), ('vdac1', 'interacts', 'hk'), ('ec50', 'interacts', 'vdac1')})",
      "chunk_text": "The Warburg phenotype's biphasic response to CBD is a direct consequence of its target affinity profile: low doses (<5 \u00b5M) favor cytoprotective TRPV1/PPAR\u03b3 signaling (EC50 2-5 \u00b5M), while cytotoxic effects only manifest when CBD concentrations approach VDAC1's Kd (11 \u00b5M) and can overcome the high-affinity HK-II \"buffer.\""
    },
    {
      "statement": "3: The synergistic apoptosis induced by 2-DG + ABT-737 arises because they multiplicatively reduce the cofactor \"clamp\" on VDAC1 oligomerization, shifting the dose-response of a VDAC1-binding molecule (e.g., CBD) leftward by a predictable factor based on occupancy reduction.",
      "mechanism": "2-DG (via G6P depletion) reduces HK-II-VDAC1 affinity, ABT-737 displaces Bcl-xL; their combined effect on the occupancy product lowers the energy barrier for VDAC1 conformational change to a pro-apoptotic state.",
      "falsifiable_by": "Testing the combination with a range of VDAC1 binders and showing synergy collapses if either cofactor's binding is rendered irreversible. \u2500\u2500\u2500",
      "type": 0,
      "confidence": 0.677,
      "overlap_count": 4,
      "models": [
        "claude",
        "deepseek",
        "grok",
        "mistral"
      ],
      "tuples": "frozenset({('abt', 'downregulates', 'vdac1'), ('cbd', 'interacts', 'vdac1'), ('g6p', 'downregulates', 'hk')})",
      "chunk_text": "3: The synergistic apoptosis induced by 2-DG + ABT-737 arises because they multiplicatively reduce the cofactor \"clamp\" on VDAC1 oligomerization, shifting the dose-response of a VDAC1-binding molecule (e.g., CBD) leftward by a predictable factor based on occupancy reduction."
    },
    {
      "statement": "1: HK-II displacement from VDAC1 is a necessary permissive step that unmasks cardiolipin microdomains, enabling Bax recruitment and lipid peroxidation\u2014the primary driver of cytochrome c release. Direct VDAC1 conductance change is a secondary consequence of this membrane remodeling.",
      "mechanism": "Displaced HK-II exposes CL, facilitating Bax insertion and ROS-induced CL peroxidation, which destabilizes the OMM and releases cyt c, while VDAC1 may subsequently adopt a sustained open state.",
      "falsifiable_by": "Demonstrating cytochrome c release and apoptosis in cells where HK-II is displaced but CL peroxidation or Bax recruitment is pharmacologically/genetically blocked.",
      "type": 1,
      "confidence": 0.773,
      "overlap_count": 3,
      "models": [
        "claude",
        "deepseek",
        "mistral"
      ],
      "tuples": "frozenset({('hk', 'interacts', 'vdac1'), ('ros', 'interacts', 'omm'), ('cl', 'interacts', 'ros'), ('cytochrome_c_release', 'interacts', 'cl'), ('vdac1', 'interacts', 'cytochrome_c_release')})",
      "chunk_text": "1: HK-II displacement from VDAC1 is a necessary permissive step that unmasks cardiolipin microdomains, enabling Bax recruitment and lipid peroxidation\u2014the primary driver of cytochrome c release. Direct VDAC1 conductance change is a secondary consequence of this membrane remodeling."
    },
    {
      "statement": "4:** Cardiolipin enrichment at the OMM lowers the apoptotic threshold by ~2-fold by stabilizing VDAC1 oligomers and facilitating Bax insertion, while cholesterol opposes this by rigidifying the membrane and stabilizing monomeric VDAC1.",
      "mechanism": "Cardiolipin's cone-shaped geometry promotes negative curvature at oligomer interfaces; cholesterol increases bilayer order, raising the energy barrier for conformational transitions required for oligomerization.",
      "falsifiable_by": "Reconstituting VDAC1 in liposomes of defined CL/cholesterol ratios and measuring oligomerization kinetics \u00b1 CBD; no lipid dependence would refute this. \u2500\u2500\u2500",
      "type": 2,
      "confidence": 0.475,
      "overlap_count": 2,
      "models": [
        "claude",
        "mistral"
      ],
      "tuples": "frozenset({('omm', 'downregulates', 'vdac1')})",
      "chunk_text": "4:** Cardiolipin enrichment at the OMM lowers the apoptotic threshold by ~2-fold by stabilizing VDAC1 oligomers and facilitating Bax insertion, while cholesterol opposes this by rigidifying the membrane and stabilizing monomeric VDAC1."
    },
    {
      "statement": "HK-II displacement is a necessary permissive event, but the irreversible death commitment is the subsequent VDAC1 oligomerization into a Bax/Bak-receptive macropore, a process allosterically promoted by exposed cardiolipin.",
      "mechanism": "Displacing HK-II unmasks VDAC1 and its proximal cardiolipin, creating a nucleation site for both VDAC1 self-assembly and Bax insertion, which are the true points of no return.",
      "falsifiable_by": "Evidence showing that a non-oligomerizing VDAC1 mutant, when HK-II is displaced, still permits Bax/Bak-mediated cytochrome c release at the same rate as wild-type.",
      "type": 3,
      "confidence": 0.85,
      "overlap_count": 1,
      "models": [
        "gemini"
      ],
      "tuples": "frozenset({('hk', 'interacts', 'vdac1')})",
      "chunk_text": "HK-II displacement is a necessary permissive event, but the irreversible death commitment is the subsequent VDAC1 oligomerization into a Bax/Bak-receptive macropore, a process allosterically promoted by exposed cardiolipin."
    },
    {
      "statement": "HK-II displacement by CBD/erastin is the primary cyt c release trigger via CL unmasking/peroxidation, secondary to VDAC conductance change; tubulin blockade acts redundantly but weaker.",
      "mechanism": "HK-II shields OMM CL from peroxidation/Bax; displacement exposes CL, recruiting Bax/oligomerizing VDAC for cyt c egress independent of channel pore dilation.",
      "falsifiable_by": "HK-II KD cells show no cyt c release or attenuated response to CBD/erastin despite conductance increase (patch-clamp + cyt c assay).",
      "type": 3,
      "confidence": 0.82,
      "overlap_count": 1,
      "models": [
        "grok"
      ],
      "tuples": "frozenset({('cbd', 'upregulates', 'cl')})",
      "chunk_text": "HK-II displacement by CBD/erastin is the primary cyt c release trigger via CL unmasking/peroxidation, secondary to VDAC conductance change; tubulin blockade acts redundantly but weaker."
    },
    {
      "statement": "The apoptotic threshold [Drug] for a VDAC1-targeting agent is inversely proportional to the fraction of \"free\" VDAC1, defined as VDAC1 not bound by either HK-II or Bcl-xL, and directly proportional to the membrane cholesterol:cardiolipin ratio.",
      "mechanism": "Both HK-II/Bcl-xL and cholesterol act as independent negative regulators of VDAC1 oligomerization, increasing the activation energy that must be overcome by the drug binding event.",
      "falsifiable_by": "A cell line with engineered high cholesterol and low HK-II expression showing the same apoptotic sensitivity to CBD as a low cholesterol, low HK-II line. \u2500\u2500\u2500",
      "type": 3,
      "confidence": 0.75,
      "overlap_count": 1,
      "models": [
        "gemini"
      ],
      "tuples": "frozenset({('vdac1', 'interacts', 'hk')})",
      "chunk_text": "The apoptotic threshold [Drug] for a VDAC1-targeting agent is inversely proportional to the fraction of \"free\" VDAC1, defined as VDAC1 not bound by either HK-II or Bcl-xL, and directly proportional to the membrane cholesterol:cardiolipin ratio."
    },
    {
      "statement": "CL enrichment lowers apoptotic [CBD] EC50 ~2-3x (11\u21924-6 \u00b5M) by promoting VDAC oligomerization/Bax insertion; cholesterol raises it equivalently by rigidifying OMM/anti-oligomer.",
      "mechanism": "CL peroxidation post-HK-II displacement facilitates VDAC hexamer cyt c channel; chol stabilizes monomeric low-conductance VDAC, blocking allosteric apo-gate.",
      "falsifiable_by": "OMM liposome swaps (high/low CL/chol) +/- CBD show no EC50 shift in cyt c flux or Bax binding (lipidomics + proteomics).",
      "type": 3,
      "confidence": 0.68,
      "overlap_count": 1,
      "models": [
        "grok"
      ],
      "tuples": "frozenset({('cbd', 'downregulates', 'cl'), ('ec50', 'upregulates', 'vdac')})",
      "chunk_text": "CL enrichment lowers apoptotic [CBD] EC50 ~2-3x (11\u21924-6 \u00b5M) by promoting VDAC oligomerization/Bax insertion; cholesterol raises it equivalently by rigidifying OMM/anti-oligomer."
    },
    {
      "statement": "Tubulin blockade reinforces Bcl-xL but not HK-II; its displacement by CBD requires >20 \u00b5M, contributing <20% to gate-shift.",
      "mechanism": "Microtubule-detached tubulin plugs VDAC semi-independently of HK-II, but low-affinity binding yields minor cytoprotection vs dominant metabolic HK-II.",
      "falsifiable_by": "Vinblastine (tubulin stabilizer) + low CBD blocks death in HK-II-low cells only. \u2500\u2500\u2500",
      "type": 3,
      "confidence": 0.55,
      "overlap_count": 1,
      "models": [
        "grok"
      ],
      "tuples": "frozenset({('cbd', 'interacts', 'vdac'), ('hk', 'interacts', 'cbd')})",
      "chunk_text": "Tubulin blockade reinforces Bcl-xL but not HK-II; its displacement by CBD requires >20 \u00b5M, contributing <20% to gate-shift."
    }
  ],
  "conflicts": [],
  "total_rounds": 0,
  "snapshots": [
    {
      "round_num": 0,
      "jaccard": 0.05742424242424242,
      "cosine": 0.7937113642692566,
      "jsd": 0.15728103989791886,
      "kappa": 0.9139384129186418,
      "type_distribution": {
        "0": 0.0,
        "1": 0.42105263157894735,
        "2": 0.47368421052631576,
        "3": 0.10526315789473684
      },
      "type_01_ratio": 0.42105263157894735,
      "n_claims_per_model": [
        4,
        4,
        5,
        3,
        3
      ]
    },
    {
      "round_num": 1,
      "jaccard": 0.5529286073403721,
      "cosine": 0.9214948177337646,
      "jsd": 0.2502283819155408,
      "kappa": 0.9470643056849951,
      "type_distribution": {
        "0": 0.47368421052631576,
        "1": 0.15789473684210525,
        "2": 0.10526315789473684,
        "3": 0.2631578947368421
      },
      "type_01_ratio": 0.631578947368421,
      "n_claims_per_model": [
        4,
        4,
        5,
        3,
        3
      ]
    }
  ]
}